| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/08/2013 | US20130202620 High concentration antibody formulations |
| 08/08/2013 | US20130202615 Anti-vegf antibodies and uses thereof |
| 08/08/2013 | US20130202604 Therapeutic Uses of Monoclonal Antibodies to the Angiotensin-II Type-1 Receptor |
| 08/08/2013 | US20130202582 Agent delivery system capable of selectively releasing an agent |
| 08/08/2013 | US20130202564 Systems and Methods of Cell Activated, Controlled Release Delivery of Growth Factors for Tissue Repair and Regeneration |
| 08/08/2013 | US20130202549 Use of dpas and co-polymers for hyperlipidemia and atherosclerosis along with reducing feeding rate and adipose tissue weight of obesity animal |
| 08/08/2013 | US20130202548 Immunomodulatory protein constructs with a helical polymeric backbone |
| 08/08/2013 | CA2856618A1 Negatively charged nucleic acid comprising complexes for immunostimulation |
| 08/08/2013 | CA2856615A1 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or pepide antigen |
| 08/08/2013 | CA2848985A1 C10rf32 antibodies, and uses thereof for treatment of cancer |
| 08/07/2013 | EP2623123A1 Oligomer-opioid agonist conjugates |
| 08/07/2013 | EP2623122A1 Coated devices and methods for coating |
| 08/07/2013 | EP2623121A1 Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen |
| 08/07/2013 | EP2623120A2 Compositions comprising dietary fat complexer and methods for their use |
| 08/07/2013 | EP2623110A1 Factor XII inhibitors for the treatment of neurological inflammatory disorders |
| 08/07/2013 | EP2623103A1 Patch |
| 08/07/2013 | EP2623102A1 Transdermal absorption preparation |
| 08/07/2013 | EP2623100A1 Preparation for improving solubility of poorly soluble drug |
| 08/07/2013 | EP2622091A2 Colon and pancreas cancer peptidomimetics |
| 08/07/2013 | EP2621541A2 Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging |
| 08/07/2013 | EP2621539A1 Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers |
| 08/07/2013 | EP2621538A2 Engineered polypeptides having enhanced duration of action |
| 08/07/2013 | EP2621537A1 Pentapeptide derivatives for promoting hair growth |
| 08/07/2013 | EP2621536A1 Amatoxin-conjugates with improved linkers |
| 08/07/2013 | EP2621535A1 Thiazolidine linker for the conjugation of drugs to antibodies |
| 08/07/2013 | EP2621526A1 Antibody drug conjugates (adc) that bind to 191p4d12 proteins |
| 08/07/2013 | EP2621523A1 Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres |
| 08/07/2013 | EP2621520A1 Collagenase g and collagenase h compositions for the treatment of diseases involving alterations of collagen |
| 08/07/2013 | EP2621509A2 Formulations of guanylate cyclase c agonists and methods of use |
| 08/07/2013 | EP2621500A2 Therapeutic use of a tlr agonist and combination therapy |
| 08/07/2013 | EP2621498A2 Combination treatment for dermatological conditions |
| 08/07/2013 | EP2621497A2 Combination treatment for rosacea |
| 08/07/2013 | EP2621496A1 Crystalline naloxol-peg conjugate |
| 08/07/2013 | EP2621468A2 Pharmaceutical composition |
| 08/07/2013 | EP2366396B1 Myocardial perfusion imaging using adenosine receptor agonists |
| 08/07/2013 | CN1515244B Protein-stable pharmacological active matter, its preparation and application method |
| 08/07/2013 | CN103237785A Enhanced transbuccal drug delivery system and compositions |
| 08/07/2013 | CN103237561A Prodrugs comprising an exendin linker conjugate |
| 08/07/2013 | CN103237559A Methods for treating autoimmune disease using biocompatible bioabsorbable nanospheres |
| 08/07/2013 | CN103237545A Pharmaceutical dosage form comprising 6'-fluoro-(N-methyl-or N,N-dimethyl-)-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain |
| 08/07/2013 | CN103237538A Inhibitor of attachment of periodontal-isease-inducing bacterium onto surfaces of teeth, oral biofilm formation inhibitor, and composition for oral applications |
| 08/07/2013 | CN103233011A Application of PEG (polyethylene glycol)-PLA (Poly Lactic Acid) nano-material-coated HBV (Hepatitis B Virus)-CpG (Cytosine Phosphate Guanosine) in prevention and/or treatment of hepatitis B |
| 08/07/2013 | CN103232574A Preparation method of stable chitosan nano-micelle with CO2 responsiveness and temperature responsiveness |
| 08/07/2013 | CN103232542A Double-target chimeric protein |
| 08/07/2013 | CN103232531A Cancer cell-targeting structural molecule and use thereof |
| 08/07/2013 | CN103232422A A light-sensitive expansionary polymer and a preparation method and applications thereof |
| 08/07/2013 | CN103232347A A brain targeting prodrug for CNS (central nervous system) drugs and a preparation method thereof, and applications of borneol in the brain targeting prodrug for CNS drugs |
| 08/07/2013 | CN103230604A Magnetic water-soluble fullerene, and preparation method and application thereof |
| 08/07/2013 | CN103230603A Preparation method of EX527 targeted multifunctional mesoporous silicon nano particle |
| 08/07/2013 | CN103230601A Rare earth doped gallium oxide drug-loading body preparation method |
| 08/07/2013 | CN103230599A Protein drug delivery system for enhancing releasing of polypeptide drug from cell endosome and application thereof |
| 08/07/2013 | CN103230598A Fusion peptide therapeutic compositions |
| 08/07/2013 | CN103230597A Composition capable of promoting smearing and penetration, and application thereof |
| 08/07/2013 | CN103230596A Gold nanometer medicament carrier with synergistic antineoplastic effect |
| 08/07/2013 | CN103230595A Composition for treating mental diseases |
| 08/07/2013 | CN103230439A Elegant jessamine sustained-release membrane and preparation method thereof |
| 08/07/2013 | CN103230432A Composition with function of auxiliarily protecting chemical hepatic injury and preparation method of capsule preparation thereof |
| 08/07/2013 | CN103230423A Compound prcetmol zinc gluconte tablet and preparation method thereof |
| 08/07/2013 | CN103230412A Compound lansoprazole capsules and preparation method thereof |
| 08/07/2013 | CN103230407A Compound glycyrrhizin capsule composition |
| 08/07/2013 | CN103230403A Anti-HIV (Human Immunodeficiency Virus) combined drug tablet |
| 08/07/2013 | CN103230385A Preparation method of transdermal drug delivery system (TDDS) |
| 08/07/2013 | CN103230382A Celecoxib effervescent tablet and preparation method thereof |
| 08/07/2013 | CN103230381A Zolpidem tartrate time-selecting pulse sustained-release pellet and preparation method thereof |
| 08/07/2013 | CN103230380A Divalproex sodium enteric-coated tablet core as well as preparation method and application thereof |
| 08/07/2013 | CN103230379A Orally disintegrating sustained-release preparation containing tamsulosin hydrochloride and preparation method thereof |
| 08/07/2013 | CN103230378A Method for preparing loratadine tablet |
| 08/07/2013 | CN103230377A Antibiosis fishing medicament processing method |
| 08/07/2013 | CN103230376A Simvastatin tablet preparation method |
| 08/07/2013 | CN103230373A Dexlansoprazole freeze-drying powder for injection and preparation method thereof |
| 08/07/2013 | CN103230372A Moxifloxacin hydrochloride freeze-dried powder injection and preparation method thereof |
| 08/07/2013 | CN103230368A Statin medicine preparation method |
| 08/07/2013 | CN103230367A Cefpodoxime proxetil composition dry suspension and preparation method thereof |
| 08/07/2013 | CN103230364A Preparation method of ceftiofur acid long-acting injection |
| 08/07/2013 | CN103230363A Antifungal oral solution |
| 08/07/2013 | CN103230362A In-situ gel for injecting flunixin meglumine and preparation method thereof |
| 08/07/2013 | CN103230012A Honeycomb essence buccal tablet and preparation process thereof |
| 08/07/2013 | CN102697713B Sodium hyaluronate eye drops and a preparation method thereof |
| 08/07/2013 | CN102688212B Isosorbide mononitrate sustained release tablet and preparation method thereof |
| 08/07/2013 | CN102675655B Water-soluble fullerene and preparation and application methods thereof |
| 08/07/2013 | CN102670566B Cyclodextrin derivative transdermal composite film agent and preparation method thereof |
| 08/07/2013 | CN102657635B Spongy asenapine sublingual film agent with micropores and preparation method thereof |
| 08/07/2013 | CN102657602B 3,5-dyhydroxyl-4-isopropyl diphenylethene chitosan gel and preparation method thereof |
| 08/07/2013 | CN102626436B Preparation method of liuwei eyesight improving pharmaceutical composition |
| 08/07/2013 | CN102579801B Traditional Chinese medicine preparation for treating diabetic syndrome and preparation method of same |
| 08/07/2013 | CN102552119B Ambroxol hydrochloride glucose injection and preparation method thereof |
| 08/07/2013 | CN102552076B Anti-allergy preparation and preparation method and application thereof |
| 08/07/2013 | CN102525978B Children amoxicillin-potassium clavulanate composition |
| 08/07/2013 | CN102499909B Itraconazole dispersible tablets and preparation method thereof |
| 08/07/2013 | CN102488828B Chinese medicinal composition for treating infectious bronchitis and its preparation method |
| 08/07/2013 | CN102475700B Daidzein concentrated solution and special diluent agent thereof |
| 08/07/2013 | CN102417695B Xylitol-based elastomer composite material and preparation method thereof |
| 08/07/2013 | CN102397525B Chinese medicinal composition with function of improving nutritional anemia and preparation method thereof |
| 08/07/2013 | CN102341091B Riluzole aqueous suspensions |
| 08/07/2013 | CN102327761B Polymer composite micro-bead and preparation method thereof |
| 08/07/2013 | CN102274477B Preparation method of sugar-free granules for treating wind-cold type common cold |
| 08/07/2013 | CN102274187B Nano structural lipid carrier and preparation method and application thereof |
| 08/07/2013 | CN102172410B Construction method of targeted nano particle transmission system for cancer diagnosis and treatment |
| 08/07/2013 | CN102048696B Preparation method of lipid nanoparticles |
| 08/07/2013 | CN102037058B Docetaxel polymer derivative, method for producing same and use of same |